{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:42:02Z","timestamp":1788486122904,"version":"build-2803163510"},"reference-count":102,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the NIH, National Cancer Institute","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Dendritic cells (DCs) are involved in human and simian immunodeficiency virus (HIV and SIV) pathogenesis but also play a critical role in orchestrating innate and adaptive vaccine-specific immune responses. Effective HIV\/SIV vaccines require strong antigen-specific CD4 T cell responses, cytotoxic activity of CD8 T cells, and neutralizing\/non-neutralizing antibody production at mucosal and systemic sites. To develop a protective HIV\/SIV vaccine, vaccine regimens including DCs themselves, protein, DNA, mRNA, virus vectors, and various combinations have been evaluated in different animal and human models. Recent studies have shown that DCs enhanced prophylactic HIV\/SIV vaccine efficacy by producing pro-inflammatory cytokines, improving T cell responses, and recruiting effector cells to target tissues. DCs are also targets for therapeutic HIV\/SIV vaccines due to their ability to reverse latency, present antigen, and augment T and B cell immunity. Here, we review the complex interactions of DCs over the course of HIV\/SIV prophylactic and therapeutic immunizations, providing new insights into development of advanced DC-targeted HIV\/SIV vaccines.<\/jats:p>","DOI":"10.3390\/v12010024","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T10:28:43Z","timestamp":1577183323000},"page":"24","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dendritic Cells in HIV\/SIV Prophylactic and Therapeutic Vaccination"],"prefix":"10.3390","volume":"12","author":[{"given":"Eun-Ju","family":"Ko","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Jeju National University, Jeju 63243, Korea"},{"name":"Interdisciplinary Graduate Program in Advanced Convergence Technology &amp; Science, Jeju National University, Jeju 63243, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Robert-Guroff","sequence":"additional","affiliation":[{"name":"Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/cti.2016.6","article-title":"Targeting dendritic cells: A promising strategy to improve vaccine effectiveness","volume":"5","author":"Macri","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.161.3.1313","article-title":"Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response","volume":"161","author":"Wykes","year":"1998","journal-title":"J. Immunol."},{"key":"ref_4","first-page":"178","article-title":"Development of human dendritic cells and their role in HIV infection: Antiviral immunity versus HIV transmission","volume":"4","author":"Muhsen","year":"2013","journal-title":"Front. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fimmu.2013.00086","article-title":"Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load","volume":"4","author":"Genovese","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.it.2013.10.003","article-title":"Dendritic cells in progression and pathology of HIV infection","volume":"35","author":"Manches","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1182\/blood-2008-05-158642","article-title":"Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway","volume":"113","author":"Archer","year":"2009","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1128\/JVI.74.13.6087-6095.2000","article-title":"Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells","volume":"74","author":"Hu","year":"2000","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1086\/314795","article-title":"T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans\u2019 cells of the female genital tract are infected with SIV","volume":"179","author":"Miller","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1084\/jem.183.1.215","article-title":"Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques","volume":"183","author":"Spira","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09337","article-title":"A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells","volume":"467","author":"Manel","year":"2010","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni.3647","article-title":"HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3","volume":"18","author":"Gringhuis","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/s41467-018-07753-2","article-title":"Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines","volume":"9","author":"McCauley","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni.1858","article-title":"HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells","volume":"11","author":"Gringhuis","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm1541","article-title":"Langerin is a natural barrier to HIV-1 transmission by Langerhans cells","volume":"13","author":"Nabatov","year":"2007","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy","volume":"18","author":"Pierson","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/COH.0000000000000281","article-title":"Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations","volume":"11","author":"Lee","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.1600343","article-title":"The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence","volume":"197","author":"Murray","year":"2016","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Qin, K., Boppana, S., Du, V.Y., Carlson, J.M., Yue, L., Dilernia, D.A., Hunter, E., Mailliard, R.B., Mallal, S.A., and Bansal, A. (2019). CD8 T cells targeting adapted epitopes in chronic HIV infection promote dendritic cell maturation and CD4 T cell trans-infection. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007970"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sachdeva, M., Sharma, A., and Arora, S.K. (2015). Functional Impairment of Myeloid Dendritic Cells during Advanced Stage of HIV-1 Infection: Role of Factors Regulating Cytokine Signaling. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140852"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.1403016","article-title":"SAMHD1 degradation enhances active suppression of dendritic cell maturation by HIV-1","volume":"194","author":"Hertoghs","year":"2015","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2018.06.012","article-title":"Immune Correlate-Guided HIV Vaccine Design","volume":"24","author":"Alter","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gao, Y., McKay, P.F., and Mann, J.F.S. (2018). Advances in HIV-1 Vaccine Development. Viruses, 10.","DOI":"10.3390\/v10040167"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/COH.0000000000000362","article-title":"Lessons learned from human HIV vaccine trials","volume":"12","author":"Pollara","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Trovato, M., D\u2019Apice, L., Prisco, A., and De Berardinis, P. (2018). HIV Vaccination: A Roadmap among Advancements and Concerns. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041241"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/cpt.1208","article-title":"HIV\/AIDS Vaccines: 2018","volume":"104","author":"Robinson","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.1000621107","article-title":"Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells","volume":"107","author":"Nchinda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mi.2015.133","article-title":"A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract","volume":"9","author":"Ruane","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fimmu.2019.00843","article-title":"Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine","volume":"10","author":"Apostolico","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.smim.2005.05.013","article-title":"Monocyte-derived dendritic cells","volume":"17","author":"Leon","year":"2005","journal-title":"Semin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2013.09.023","article-title":"Monocyte-derived dendritic cells: Targets as potent antigen-presenting cells for the design of vaccines against infectious diseases","volume":"19","author":"Qu","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.vaccine.2005.01.052","article-title":"Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: Preclinical studies in the SHIV-rhesus model","volume":"23","author":"Nehete","year":"2005","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1128\/JVI.02611-08","article-title":"Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells","volume":"83","author":"Colleton","year":"2009","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1034\/j.1600-0684.2000.290312.x","article-title":"Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses","volume":"29","author":"Zhu","year":"2000","journal-title":"J. Med. Primatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1172\/JCI23467","article-title":"Developing DNA vaccines that call to dendritic cells","volume":"114","author":"Kutzler","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1172\/JCI200422608","article-title":"Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines","volume":"114","author":"Sumida","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: A novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI34224","article-title":"The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells","volume":"118","author":"Nchinda","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Pitisuttithum","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1128\/JVI.00310-06","article-title":"Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes","volume":"80","author":"Wang","year":"2006","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-4690-8-48","article-title":"A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells","volume":"8","author":"Melchers","year":"2011","journal-title":"Retrovirology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.4049\/jimmunol.170.5.2496","article-title":"Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand","volume":"170","author":"Sailaja","year":"2003","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10850","DOI":"10.1128\/JVI.77.20.10850-10861.2003","article-title":"Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4","volume":"77","author":"Nayak","year":"2003","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1172\/JCI64704","article-title":"PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice","volume":"123","author":"Zhou","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/14760584.2016.1141054","article-title":"Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination","volume":"15","author":"Glass","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Hobernik, D., and Bros, M. (2018). DNA Vaccines-How Far from Clinical Use?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113605"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2014.09.010","article-title":"Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses","volume":"32","author":"Climent","year":"2014","journal-title":"Vaccine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/nl300027p","article-title":"Surface-engineered gold nanorods: Promising DNA vaccine adjuvant for HIV-1 treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Nano Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.nano.2017.11.009","article-title":"Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses","volume":"14","author":"Climent","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0022-202X.2004.23535.x","article-title":"DermaVir: A novel topical vaccine for HIV\/AIDS","volume":"124","author":"Lisziewicz","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Francica, J.R., Laga, R., Lynn, G.M., Muzikova, G., Androvic, L., Aussedat, B., Walkowicz, W.E., Padhan, K., Ramirez-Valdez, R.A., and Parks, R. (2019). Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000328"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/hum.2018.161","article-title":"Comparison of Dendritic Cell Activation by Virus-Based Vaccine Delivery Vectors Emphasizes the Transcriptional Downregulation of the Oxidative Phosphorylation Pathway","volume":"30","author":"Tsitoura","year":"2019","journal-title":"Hum. Gene. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Alayo, Q.A., Provine, N.M., and Penaloza-MacMaster, P. (2017). Novel Concepts for HIV Vaccine Vector Design. mSphere, 2.","DOI":"10.1128\/mSphere.00415-17"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt1390","article-title":"Engineered lentivector targeting of dendritic cells for in vivo immunization","volume":"26","author":"Yang","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/mi.2011.1","article-title":"Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells","volume":"4","author":"Ganguly","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1132742","article-title":"Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells","volume":"314","author":"Mora","year":"2006","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/CVI.00010-12","article-title":"Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route","volume":"19","author":"Patterson","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2019.00779","article-title":"Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses","volume":"10","author":"Ko","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1084\/jem.20081786","article-title":"Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells","volume":"205","author":"Perreau","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"19940","DOI":"10.1073\/pnas.0907898106","article-title":"Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1","volume":"106","author":"Benlahrech","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.virol.2014.09.004","article-title":"Different HIV pox viral vector-based vaccines and adjuvants can induce unique antigen presenting cells that modulate CD8 T cell avidity","volume":"468\u2013470","author":"Trivedi","year":"2014","journal-title":"Virology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41467-019-08739-4","article-title":"HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge","volume":"10","author":"Jones","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JVI.01443-08","article-title":"Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses","volume":"83","author":"Carnero","year":"2009","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1128\/JVI.02036-10","article-title":"Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice","volume":"85","author":"Maamary","year":"2011","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"eaal1329","DOI":"10.1126\/sciimmunol.aal1329","article-title":"Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation","volume":"2","author":"Kim","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm0703-861","article-title":"Immunopathogenesis and immunotherapy in AIDS virus infections","volume":"9","author":"Letvin","year":"2003","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1126\/science.1100600","article-title":"Therapeutic vaccines for chronic infections","volume":"305","author":"Autran","year":"2004","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garcia","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1080\/21505594.2017.1356535","article-title":"Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-alpha to reactivate HIV-1 from latency","volume":"8","author":"Ren","year":"2017","journal-title":"Virulence"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ebiom.2019.03.077","article-title":"Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1","volume":"43","author":"Kristoff","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1385\/IR:36:1:265","article-title":"Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model","volume":"36","author":"Brown","year":"2006","journal-title":"Immunol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/COH.0000000000000491","article-title":"Therapeutic vaccination for HIV: Hopes and challenges","volume":"13","author":"Stephenson","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_80","first-page":"279","article-title":"Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients","volume":"19","author":"Levy","year":"2005","journal-title":"AIDS"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.aids.0000206504.09159.d3","article-title":"Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals","volume":"20","author":"Levy","year":"2006","journal-title":"AIDS"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Brezar, V., Hani, L., Surenaud, M., Hubert, A., Lacabaratz, C., Lelievre, J.D., Levy, Y., and Seddiki, N. (2017). Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006489"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clim.2011.10.010","article-title":"A phase I\/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption","volume":"142","author":"Allard","year":"2012","journal-title":"Clin. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"van den Ham, H.J., Cooper, J.D., Tomasik, J., Bahn, S., Aerts, J.L., Osterhaus, A., Gruters, R.A., Andeweg, A.C., and Investigators, D.-T.T. (2018). Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192278"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Surenaud, M., Montes, M., Lindestam Arlehamn, C.S., Sette, A., Banchereau, J., Palucka, K., Lelievre, J.D., Lacabaratz, C., and Levy, Y. (2019). Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008011"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/excr.2002.5497","article-title":"HIV-1 Nef induces dendritic cell differentiation: A possible mechanism of uninfected CD4(+) T cell activation","volume":"275","author":"Quaranta","year":"2002","journal-title":"Exp. Cell Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1096\/fj.06-6260rev","article-title":"The immunoregulatory effects of HIV-1 Nef on dendritic cells and the pathogenesis of AIDS","volume":"20","author":"Quaranta","year":"2006","journal-title":"FASEB J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1128\/JVI.79.13.7990-8003.2005","article-title":"Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: Implications for viral immune escape","volume":"79","author":"Majumder","year":"2005","journal-title":"J. Virol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/14712598.2014.950652","article-title":"Advances in dendritic cell immunotherapies for HIV-1 infection","volume":"14","author":"Miller","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.163.3.1666","article-title":"Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: Implications for immunotherapy","volume":"163","author":"Chougnet","year":"1999","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-2478(98)00169-2","article-title":"Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses","volume":"66","author":"Sapp","year":"1999","journal-title":"Immunol. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4161\/hv.25876","article-title":"Dendritic cell based vaccines for HIV infection: The way ahead","volume":"9","author":"Garcia","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2796.2008.02047.x","article-title":"Dendritic cell-based human immunodeficiency virus vaccine","volume":"265","author":"Rinaldo","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"Lu","year":"2004","journal-title":"Nat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm806","article-title":"Therapeutic dendritic-cell vaccine for simian AIDS","volume":"9","author":"Lu","year":"2003","journal-title":"Nat. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.vaccine.2011.07.043","article-title":"Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1","volume":"29","author":"Garcia","year":"2011","journal-title":"Vaccine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-4690-9-72","article-title":"Can immunotherapy be useful as a \"functional cure\" for infection with Human Immunodeficiency Virus-1?","volume":"9","author":"Vanham","year":"2012","journal-title":"Retrovirology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3389\/fimmu.2018.02993","article-title":"Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?","volume":"9","author":"Santillo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/QAD.0000000000001276","article-title":"Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)","volume":"31","author":"Guardo","year":"2017","journal-title":"AIDS"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2018.12.019","article-title":"Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation","volume":"195","author":"Coolen","year":"2019","journal-title":"Biomaterials"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.2217\/nnm.14.172","article-title":"Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: Steps toward their clinical evaluation","volume":"9","author":"Climent","year":"2014","journal-title":"Nanomedicine (Lond.)"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/24\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:45:07Z","timestamp":1760190307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/1\/24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,24]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["v12010024"],"URL":"https:\/\/doi.org\/10.3390\/v12010024","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,24]]}}}